Evidence map›Paper›PMID 19298660›Full record

ArticleBMC immunology2009

Tumor necrosis factor-alpha induced expression of matrix metalloproteinase-9 through p21-activated kinase-1.

Ling Zhou, Chunli Yan, Roben G Gieling, Yujiro Kida, Warren Garner, Wei Li, Yuan-Ping Han

Open access · goldAbstract read
In one paragraph

Article in BMC immunology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 77 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Pathophysiology of Lung Disease and Wound Repair in Cystic Fibrosis.Pathophysiology : the official journal of the International Society for Pathophysiology · 2021
    Review
  16. Review
  17. A Novel PAK1-Notch1 Axis Regulates Crypt Homeostasis in Intestinal Inflammation.Cellular and molecular gastroenterology and hepatology · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ling ZhouKeck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA. lingzhou@usc.edu
Chunli Yan
Roben G Gieling
Yujiro Kida
Warren Garner
Wei Li
Yuan-Ping Han
University of Southern California · US

Funding

NON-PARENCHYMAL LIVER CELL CORER24AA012885 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TSUKAMOTO, HIDEKAZU · 2001 to 2025
$8.1M
Hepatic Stellate Cell Derived MMP9 in Liver FibrogenesisR01DK069418 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HAN, YUAN-PING · 2004 to 2008
$1.5M
Cytokine induced abnormal wound healingR01GM050967 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GARNER, WARREN L. · 2002 to 2005
$1.2M
ACT,a pathophysiological inhibitor of MMP-9 activationR01AR051558 · NIAMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HAN, YUAN-PING · 2004 to 2008
$1.1M
MECHANISM OF HYPERTROPHIC SCARRING AFTER THERMAL TRAUMAR29GM050967 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GARNER, WARREN L. · 1995 to 1999
–
NIAAA NIH HHS R24 AA012885NIAAA NIH HHS R24 AA12885NIAMS NIH HHS AR051558NIAMS NIH HHS R01 AR051558NIDDK NIH HHS DK069418NIDDK NIH HHS R01 DK069418NIGMS NIH HHS GM50967NIGMS NIH HHS R01 GM050967NIGMS NIH HHS R29 GM050967
6 · The paper itself

Abstract

backgroundExpressed in embryonic development, matrix metalloprotein-9 (MMP-9) is absent in most of developed adult tissues, but recurs in inflammation during tissue injury, wound healing, tumor formation and metastasis. Expression of MMP-9 is tightly controlled by extracellular cues including pro-inflammatory cytokines and extracellular matrix (ECM). While the pathologic functions of MMP-9 are evident, the intracellular signaling pathways to control its expression are not fully understood. In this study we investigated mechanism of cytokine induced MMP-9 with particular emphasis on the role of p21-activated-kinase-1 (PAK1) and the down stream signaling.

resultsIn response to TNF-alpha or IL-1alpha, PAK1 was promptly activated, as characterized by a sequential phosphorylation, initiated at threonine-212 followed by at threonine-423 in the activation loop of the kinase, in human skin keratinocytes, dermal fibroblasts, and rat hepatic stellate cells. Ectopic expression of PAK1 variants, but not p38 MAP kinase, impaired the TNF-alpha-induced MMP-9 expression, while other MMPs such as MMP-2, -3 and -14 were not affected. Activation of Jun N-terminal kinase (JNK) and NF-kappaB has been demonstrated to be essential for MMP-9 expression. Expression of inactive PAK1 variants impaired JNK but not NF-kappaB activation, which consequently suppressed the 5'-promoter activities of the MMP-9 gene. After the cytokine-induced phosphorylation, both ectopically expressed and endogenous PAK1 proteins were promptly accumulated even in the condition of suppressing protein synthesis, suggesting the PAK1 protein is stabilized upon TNF-alpha stimulation. Stabilization of PAK1 protein by TNF-alpha treatment is independent of the kinase catalytic activity and p21 GTPase binding capacities. In contrast to epithelial cells, mesenchymal cells require 3-dimensional type-I collagen in response to TNF-alpha to massively express MMP-9. The collagen effect is mediated, in part, by boost JNK activation in a way to cooperate the cytokine signaling.

conclusionWe identified a novel mechanism for MMP-9 expression in response to injury signals, which is mediated by PAK1 activation and stabilization leading JNK activation.

Indexed as

Blotting, WesternCollagen Type IFibroblastsGene ExpressionGene Expression RegulationHumansKeratinocytesMatrix Metalloproteinase 9p21-Activated KinasesPhosphorylationReverse Transcriptase Polymerase Chain ReactionSignal TransductionTumor Necrosis Factor-alphaWound HealingCollagen Type IMatrix Metalloproteinase 9p21-Activated KinasesTumor Necrosis Factor-alpha

Identifiers

PMID19298660
PMCPMC2669056
OpenAlexW1998199805

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.